scispace - formally typeset
A

Alkiviadis Vatopoulos

Researcher at University of the West

Publications -  107
Citations -  14286

Alkiviadis Vatopoulos is an academic researcher from University of the West. The author has contributed to research in topics: Klebsiella pneumoniae & Antibiotic resistance. The author has an hindex of 37, co-authored 106 publications receiving 11461 citations. Previous affiliations of Alkiviadis Vatopoulos include Hellenic Centre for Diseases Control and Prevention & National and Kapodistrian University of Athens.

Papers
More filters
Journal ArticleDOI

Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study.

Hajo Grundmann, +94 more
TL;DR: The development of a consistent sampling framework and the results of the first structured survey on the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European hospitals are reported.
Journal ArticleDOI

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria

TL;DR: This document is intended to be used for educational purposes only and should not be relied on as a guide for making decisions about major decisions about torrential downpours.
Journal ArticleDOI

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues

TL;DR: Criteria must be established for which isolates should be suspected and screened for carbapenemase production, and for which tests (phenotypic and/or genotypic) should be adopted for confirmation of the resistance mechanism, and strategies should be devised for surveillance of carbapanemase producers in order to enable the implementation of effective surveillance programmes.
Journal ArticleDOI

Carbapenem-non-susceptible Enterobacteriaceae in Europe: Conclusions from a meeting of national experts

TL;DR: A consultation of experts from 31 countries set out to identify the gaps in diagnostic and response capacity, to index the magnitude of carbapenem-non-susceptibility across Europe using a novel five-level staging system, and to provide elements of a strategy to combat this public health issue in a concerted manner.